US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist
  • 0.203
  • +0.001+0.50%
Close Dec 20 16:00 ET
  • 0.208
  • +0.005+2.66%
Post 20:01 ET
17.07MMarket Cap-0.68P/E (TTM)

BioLine Rx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioLine Rx Q3 2024 Earnings Date

Currency：USDNov 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
5.29M
4.94M
-347.33K
Miss Est.
--
--
-6.57%
EPS
-0.07
-0.07
-<0.01
Miss Est.
+76.69%
+75.73%
-4.16%
Analyst Rating
Buy

Dec 21, 2024

BioLine Rx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 792.000K--
--2024/Q4-- / 7.718M--
Nov 25, 20242024/Q34.943M / 5.290M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 792.000K--
--2024/Q4-- / 7.718M--
Nov 25, 20242024/Q34.943M / 5.290M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--

Unlock Free Earnings Estimates

BioLine Rx Earnings Reports

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 25 20:12

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 21 19:54

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 20 04:36

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 15 19:12

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data